Chemoinformaics analysis of SCILLARENIN-3-O-RHAMNOSIDE
Molecular Weight | 530.658 | nRot | 3 |
Heavy Atom Molecular Weight | 488.322 | nRig | 33 |
Exact Molecular Weight | 530.288 | nRing | 6 |
Solubility: LogS | -3.324 | nHRing | 2 |
Solubility: LogP | 2.37 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
nHA | 8 | APOL | 84.5213 |
nHD | 4 | BPOL | 48.2107 |
QED | 0.439 |
Synth | 5.052 |
Natural Product Likeliness | 2.731 |
NR-PPAR-gamma | 0.624 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.011 |
Pgp-sub | 0.031 |
HIA | 0.879 |
CACO-2 | -4.991 |
MDCK | 0.0000184 |
BBB | 0.337 |
PPB | 0.940046 |
VDSS | 1.999 |
FU | 0.0523468 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.795 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.79 |
CYP2c9-inh | 0.041 |
CYP2c9-sub | 0.366 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.753 |
CYP3a4-inh | 0.115 |
CYP3a4-sub | 0.266 |
CL | 2.549 |
T12 | 0.046 |
hERG | 0.05 |
Ames | 0.07 |
ROA | 0.982 |
SkinSen | 0.015 |
Carcinogencity | 0.694 |
EI | 0.004 |
Respiratory | 0.917 |
NR-Aromatase | 0.788 |
Antiviral | Yes |
Prediction | 0.855874 |